Company Details
|
|
Address
|
15-19 Athol St, Douglas, IM1 1LB
|
|
Telephone
|
020 7016 8821
|
|
Fax
|
020 7016 9100
|
Executives
|
|
Chairman
|
Richard Mansell-Jones (2.10% holding)
|
|
Chief Executive
|
Richard Morgan (16.30% holding)
|
|
Finance Director
|
Robert Bertoldi (6.30% holding)
|
|
Non-Exec Director
|
Richard Macaleer (15.30% holding)
|
Main Shareholders
|
|
|
Amphion Capital Partners: 7.8% Mint Invest: 4.9% Ivory Overseas: 4.1% Jonathan Gold: 4%
|
Advisers
|
|
Nominated Adviser
|
Charles Stanley
|
|
Nominated Broker
|
Charles Stanley
|
|
Solicitors
|
Richards Butler
|
|
Auditors
|
Deloitte
|
|
Registrar
|
Neville Registrars
|
|
Commentary
|
|
Developer of companies in technology and life sciences
|
Company Data |
| Code |
AMP |
| Sedol |
GB00B0DJNP |
| Shares In Issue |
130.379 m |
| Indices
|
|
| Entry on AIM |
23/08/2005 |
| Interim Results |
Aug |
| Final Results |
Mar |
| Year End |
Dec |
| Accounts Due |
May |
| Int div payment |
n/a |
| Fin div payment |
n/a |
| Int net div per share |
nil |
| Fin net div per share |
nil |
| Probable CGT relief |
|
| |
|
|